Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Asset Writedowns and Impairment (2019)

Jaguar Health (JAGX) has disclosed Asset Writedowns and Impairment for 1 consecutive years, with $4.0 million as the latest value for Q2 2019.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A to $4.0 million in Q2 2019 year-over-year; TTM through Jun 2020 was $4.0 million, a N/A change, with the full-year FY2023 number at $371000.0, changed N/A from a year prior.
  • Asset Writedowns and Impairment was $4.0 million for Q2 2019 at Jaguar Health.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $4.0 million in Q2 2019 to a low of $4.0 million in Q2 2019.